Manuel Alejandro Sousa Escandón-rekin lankidetzan egindako argitalpenak (2)

2023

  1. Hyperthermic Mitomycin C in Intermediate-risk Non-muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial

    European urology oncology, Vol. 6, Núm. 1, pp. 58-66

2021

  1. Long-term experience with hyperthermic chemotherapy (Hivec) using mitomycin-c in patients with non-muscle invasive bladder cancer in Spain

    Journal of Clinical Medicine, Vol. 10, Núm. 21